Cargando…

Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromes

Drug testing assays in hematopoietic stem and progenitor cells (HSPCs) are fundamental in biological studies of myelodysplastic syndromes (MDS) but have historically entailed a technical challenge. This protocol allows the efficient isolation of MDS HSPCs from bone marrow mononuclear cell fractions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ganan-Gomez, Irene, Clise-Dwyer, Karen, Colla, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568884/ https://www.ncbi.nlm.nih.gov/pubmed/36240061 http://dx.doi.org/10.1016/j.xpro.2022.101764

Ejemplares similares

A simple score derived from bone marrow immunophenotyping is important for prognostic evaluation in myelodysplastic syndromes
por: Vido-Marques, J. R., et al.
Publicado: (2020)

Bone marrow niches in myelodysplastic syndromes
por: Tosato, Giovanna, et al.
Publicado: (2021)

Immunophenotypic changes of monocytes in myelodysplastic syndrome and clinical significance
por: Li, Lijuan, et al.
Publicado: (2022)

The growth of myelodysplastic bone marrow in long-term cultures.
por: Borbenyi, Z., et al.
Publicado: (1987)

Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update
por: Jain, Akriti G., et al.
Publicado: (2022)

Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes
por: Kouroukli, Olga, et al.
Publicado: (2022)

Flow-cytometry-based protocols for human blood/marrow immunophenotyping with minimal sample perturbation
por: Rico, Laura G., et al.
Publicado: (2021)

Injectable bone marrow microniches by co-culture of HSPCs with MSCs in 3D microscaffolds promote hematopoietic reconstitution from acute lethal radiation
por: Liang, Haiwei, et al.
Publicado: (2022)

Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome
por: Corrao, Kristen, et al.
Publicado: (2022)

Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)‐mutant myelodysplastic syndromes subtype
por: Duetz, Carolien, et al.
Publicado: (2021)

Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores
por: Reis-Alves, Suiellen C., et al.
Publicado: (2013)

Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts
por: Adema, Vera, et al.
Publicado: (2022)

Myeloblasts transition to megakaryoblastic immunophenotypes over time in some patients with myelodysplastic syndromes
por: Ogata, Kiyoyuki, et al.
Publicado: (2023)

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
por: Ganan-Gomez, Irene, et al.
Publicado: (2022)

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
por: Montalban-Bravo, Guillermo, et al.
Publicado: (2018)

Morphological and Immunophenotypical Changes of Human Bone Marrow Adipocytes in Marrow Metastasis and Myelofibrosis
por: Dello Spedale Venti, Michele, et al.
Publicado: (2022)

Practical Guide to Bone Marrow Sampling for Suspected Myelodysplastic Syndromes
por: Ridgeway, Jean A., et al.
Publicado: (2017)

Novel Protocol for the Preparation of Porcine Bone Marrow Primary Cell Culture for African Swine Fever Virus Isolation
por: Puzankova, Olga, et al.
Publicado: (2023)

Isolation of human bone marrow stromal cells from bone marrow biopsies for single-cell RNA sequencing
por: Gleitz, Hélène F.E., et al.
Publicado: (2021)

Immunophenotyping of Peripheral Blood and Bone Marrow Cells by Flow Cytometry
por: Akanni, EO, et al.
Publicado: (2006)

Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
por: Ganan-Gomez, Irene, et al.
Publicado: (2022)

Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study
por: Wu, Yi-Feng, et al.
Publicado: (2022)

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression
por: van Spronsen, Margot F., et al.
Publicado: (2023)

A protocol for human bone marrow adipocyte isolation and purification
por: Attané, Camille, et al.
Publicado: (2021)

Human bocavirus is not detectable in bone marrow from patients with myelodysplastic syndromes
por: Schildgen, Verena, et al.
Publicado: (2011)

Analysis of Immune-Cell Distribution of Bone Marrow in Patients with Myelodysplastic Syndrome
por: Lin, Chun-Liang, et al.
Publicado: (2023)

Preparation and culture of bone marrow-derived macrophages from mice for functional analysis
por: Toda, Gotaro, et al.
Publicado: (2020)

Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation
por: Rodriguez-Sevilla, Juan Jose, et al.
Publicado: (2023)

IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes
por: de Melo Campos, Paula, et al.
Publicado: (2018)

Increased Expression of Interferon Signaling Genes in the Bone Marrow Microenvironment of Myelodysplastic Syndromes
por: Kim, Miyoung, et al.
Publicado: (2015)

Immune checkpoints bone marrow expression as the predictor of clinical outcome in myelodysplastic syndrome
por: Tcvetkov, Nikolai, et al.
Publicado: (2020)

Nature or Nurture? Role of the Bone Marrow Microenvironment in the Genesis and Maintenance of Myelodysplastic Syndromes
por: Mian, Syed A., et al.
Publicado: (2021)

Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes
por: Xing, Tong, et al.
Publicado: (2022)

Protocol to isolate and analyze mouse bone marrow derived dendritic cells (BMDC)
por: Sauter, Manuela, et al.
Publicado: (2022)

P1401: UNBIASED, LONGITUDINAL ANALYSIS OF THE INFLAMMATORY RESPONSE OF HSPCS AT THE SINGLE CELL LEVEL RESOLVES CONTROVERSIES REGARDING THE HSPCS STRESS RESPONSE
por: Demerdash, Y., et al.
Publicado: (2022)

Bone Marrow Involvement by Aggressive B Cell Lymphoma Undetected by Aspirate Immunophenotyping
por: Moshref Razavi, Habib
Publicado: (2021)

PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
por: Trubkina, Hanna, et al.
Publicado: (2023)

A protocol to isolate bone marrow innate lymphoid cells for alymphoid mouse reconstitution
por: Jacquelot, Nicolas, et al.
Publicado: (2022)

High-Throughput Mass Cytometry Staining for Immunophenotyping Clinical Samples
por: Thrash, Emily M., et al.
Publicado: (2020)

Murine brain tumor microenvironment immunophenotyping using mass cytometry
por: McClellan, Brandon L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r777abn5n7v6dqmim1qduurkqv